ED
OPA.U

Exane Derivatives’s Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant OPA.U Stock Holding History

Exane Derivatives’s Portfolio OPA.U Stock Details OPA.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-41,000
Closed -$409K – 1096
2021
Q2 		$409K Hold
41,000
– – 0.09% 231
2021
Q1 		$405K Buy
+41,000
New +$405K 0.12% 173

Other funds holding OPA.U

AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TIAM
TT International Asset Management London, United Kingdom $783M AUM 104.75% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
SMC
S. Muoio & Co New York $75.7M AUM 42.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Exane Derivatives's OPA.U Position: Q3 2021 in Review

Exane Derivatives sold out of Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant (OPA.U) in Q3 2021, closing a stake of 41,000 shares — an estimated $409K sold.

Exane Derivatives first reported a position in OPA.U in Q1 2021 and held it in 2 quarters. The position peaked at $409K in Q2 2021. 12 funds tracked by Wall St. Rank hold OPA.U as of Q3 2021.

  • Exane Derivatives reported no remaining Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant position as of Q3 2021 after selling out during the quarter.
  • Exane Derivatives sold 41,000 Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant shares in Q3 2021, an estimated $409K.
  • Exane Derivatives first reported a position in Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant in Q1 2021 and held it in 2 quarters.
  • Exane Derivatives's Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant position peaked at $409K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant as of Q3 2021.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.